CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

Purpose: Homing of malignant lymphocytes to the central nervous system (CNS) may play a role in the pathogenesis of CNS lymphoma. In this study, we evaluated the chemokines CXCL12 and CXCL13 in the cerebrospinal fluid (CSF) and serum of patients with CNS lymphoma. Experimental Design: Samples from 30 patients with CNS lymphoma (23 with primary and 7 with secondary CNS lymphoma; all B-cell lymphoma) and 40 controls (10 patients with other CNS malignancies and 30 without a malignant CNS disease) were examined. CXCL12 and CXCL13 concentrations were measured using enzyme-linked immunosorbent assays. The grade of blood-brain barrier disruption was estimated by the CSF/serum albumin ratio. Results: CNS lymphoma patients and controls did not differ in CXCL12 serum and CSF levels. Serum levels of CXCL13 were generally low. CXCL13 CSF levels, however, were significantly higher in CNS lymphoma patients as compared with controls (P < 0.0001). Chemokine levels in CSF and serum did not correlate. In CNS lymphoma, CXCL13 concentration in CSF correlated with the degree of blood-brain barrier disruption (R = 0.66; P = 0.003). Elevated CSF levels of CXCL12 and CXCL13 measured in seven CNS lymphoma patients during therapy decreased in five patients who responded to chemotherapy and increased in two with lymphoma progression. Conclusions: Our results suggest a production of CXCL13 within the CNS of CNS lymphoma patients, which decreases with response to therapy. Thus, CXCL13 may represent a marker for further diagnostic and prognostic studies. (Clin Cancer Res 2009;15(19):5968–73)

[1]  M. Trojano,et al.  Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion , 2003, Clinical chemistry and laboratory medicine.

[2]  G. Bernardi,et al.  Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS , 2003, Journal of leukocyte biology.

[3]  Francis Y. Lee,et al.  Stromal cell‐derived factor 1 (SDF‐1, CXCL12) is increased in subacromial bursitis and downregulated by steroid and nonsteroidal anti‐inflammatory agents , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.

[5]  P. Fitzgerald-Bocarsly,et al.  The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis , 2005, Annals of neurology.

[6]  Justine R. Smith,et al.  Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. , 2003, Blood.

[7]  Frederick W. Fraunfelder,et al.  B-Cells in ocular adnexal lymphoproliferative lesions express B-cell attracting chemokine 1 (CXCL13). , 2005, American journal of ophthalmology.

[8]  Jason G. Cyster,et al.  A chemokine-driven positive feedback loop organizes lymphoid follicles , 2000, Nature.

[9]  B. Giannotti,et al.  BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders. , 2003, European journal of cancer.

[10]  G. Reifenberger,et al.  Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma , 2007, Acta Neuropathologica.

[11]  A. Chang,et al.  CXC Chemokine Ligand 13 and CC Chemokine Ligand 19 Cooperatively Render Resistance to Apoptosis in B Cell Lineage Acute and Chronic Lymphocytic Leukemia CD23+CD5+ B Cells1 , 2006, The Journal of Immunology.

[12]  Mónica Sala-Valdés,et al.  Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non‐Hodgkin lymphomas with widespread nodular dissemination , 2004, Journal of leukocyte biology.

[13]  M. Keating,et al.  Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. , 2007, Blood.

[14]  L. Trentin,et al.  Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. , 2004, Blood.

[15]  E. Thiel,et al.  Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma. , 2005, Blood.

[16]  D. Hess,et al.  SDF‐1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury , 2004, Journal of neuropathology and experimental neurology.

[17]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[18]  J. Blay,et al.  Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[20]  N. Harris,et al.  Pathology with clinical correlations of primary central nervous system non‐Hodgkin's lymphoma. The massachusetts general hospital experience 1958‐1989 , 1994, Cancer.

[21]  Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. , 2007, American journal of clinical pathology.

[22]  S. Berrih-Aknin,et al.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. , 2006, Blood.

[23]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[24]  A. Uccelli,et al.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Zou,et al.  Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. , 2007, American journal of physiology. Cell physiology.

[26]  J. Cyster,et al.  Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5 , 2004, Nature Immunology.

[27]  Paolo Ghia,et al.  CXCL13 (BCA‐1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells , 2002, British journal of haematology.